Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 1;27(10):e796-e803.
doi: 10.1093/oncolo/oyac133.

International Survey on Frailty Assessment in Patients with Cancer

Giuseppe Luigi Banna  1   2 , Ornella Cantale  3 , Maria Monica Haydock  2 , Nicolò Matteo Luca Battisti  4 , Kevin Bambury  5 , Naja Musolino  6 , Eoin O'Carroll  5 , Giuseppe Maltese  7   8 , Lucia Garetto  1 , Alfredo Addeo  9 , Fabio Gomes  10
Affiliations

International Survey on Frailty Assessment in Patients with Cancer

Giuseppe Luigi Banna et al. Oncologist. .

Abstract

Background: Frailty negatively affects the outcomes of patients with cancer, and its assessment might vary widely in the real world. The objective of this study was to explore awareness and use of frailty screening tools among the ONCOassist healthcare professionals (HCPs) users.

Materials and methods: We sent 2 emails with a cross-sectional 15-item survey in a 3-week interval between April and May 2021. Differences in the awareness and use of tools according to respondents' continents, country income, and job types were investigated.

Results: Seven hundred thirty-seven HCPs from 91 countries (81% physicians, 13% nurses, and 5% other HCPs) completed the survey. Three hundred and eighty-five (52%) reported assessing all or the majority of their patients; 518 (70%) at baseline and before starting a new treatment. Three hundred and four (43%) HCPs were aware of performance status (PS) scores only, 309 (42%) age/frailty/comorbidity (AFC) screening, and 102 (14%) chemotoxicity predictive tools. Five hundred and thirty-seven (73%) reported using tools; 423 (57%) just PS, 237 (32%) AFC, and 60 (8%) chemotoxicity ones. Reasons for tools non-use (485 responders) were awareness (70%), time constraints (28%), and uselessness (2%). There were significant differences in awareness and use of screening tools among different continents, country income, job types, and medical specialties (P < .001 for all comparisons).

Conclusion: Among selected oncology HCPs, there is still a worldwide lack of knowledge and usage of frailty screening tools, which may differ according to their geography, country income, and education. Targeted initiatives to raise awareness and education are needed to implement frailty assessment in managing patients with cancer.

Keywords: app; cancer; e-health; frailty; older; survey.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Awareness and use of frailty screening tools (737 respondents).
See this image and copyright information in PMC

References

    1. Ethun CG, Bilen MA, Jani AB, et al. . Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology. CA Cancer J Clin. 2017;67:362-377. 10.3322/caac.21406 - DOI - PubMed
    1. Checa-Lopez M, Oviedo-Briones M, Pardo-Gomez A, et al. . Frailtools study protocol: a comprehensive validation of frailty assessment tools to screen and diagnose frailty in different clinical and social settings and to provide instruments for integrated care in older adults. BMC Geriatr. 2019;19:86. 10.1186/s12877-019-1042-1 - DOI - PMC - PubMed
    1. Gilardi F, Capanna A, Ferraro M, et al. . Frailty screening and assessment tools: a review of characteristics and use in public health. Annali di igiene: medicina preventiva e di comunita. 2018;30:128-139. - PubMed
    1. Siegel RL, Miller KD, Jemal A.. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7-30. 10.3322/caac.21590 - DOI - PubMed
    1. Handforth C, Clegg A, Young C, et al. . The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol. 2015;26:1091-1101. - PubMed

Publication types